Fan Jin

Active 1990–2025

215
Papers
25,983
Citations
83
h-index
170
i10-index

Citations

Citations per year for Fan Jin1978: 1 citations1990: 1 citations1992: 1 citations1993: 3 citations1994: 3 citations1995: 4 citations1996: 5 citations1997: 13 citations1998: 25 citations1999: 35 citations2000: 43 citations2001: 73 citations2002: 107 citations2003: 159 citations2004: 152 citations2005: 186 citations2006: 174 citations2007: 152 citations2008: 176 citations2009: 139 citations2010: 122 citations2011: 112 citations2012: 110 citations2013: 126 citations2014: 131 citations2015: 156 citations2016: 171 citations2017: 178 citations2018: 210 citations2019: 523 citations2020: 770 citations2021: 1,061 citations2022: 1,014 citations2023: 809 citations2024: 1,239 citations2025: 726 citations2026: 46 citations1979–1989: no citations, so these years are not shown1991: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,030 citing papers, 22.8% of this breakdownChina: 2,279 citing papers, 17.1% of this breakdownUnited Kingdom: 749 citing papers, 5.6% of this breakdownItaly: 648 citing papers, 4.9% of this breakdownGermany: 536 citing papers, 4% of this breakdownFrance: 534 citing papers, 4% of this breakdownJapan: 442 citing papers, 3.3% of this breakdownCanada: 407 citing papers, 3.1% of this breakdownAustralia: 376 citing papers, 2.8% of this breakdownSpain: 354 citing papers, 2.7% of this breakdownIndia: 290 citing papers, 2.2% of this breakdownNetherlands: 276 citing papers, 2.1% of this breakdown
0%22.8%Other 25.4%

Fields

  • Medicine54.6%
  • Biochemistry, Genetics and Molecular Biology22%
  • Computer Science9.7%
  • Engineering4.3%
  • Immunology and Microbiology3%
  • Environmental Science2%
  • Other4.4%

Topics

  • Cancer Immunotherapy and Biomarkers7.1%
  • Head and Neck Cancer Studies2.4%
  • Chaos-based Image/Signal Encryption2.3%
  • Melanoma and MAPK Pathways1.7%
  • Cancer Genomics and Diagnostics1.6%
  • Immunotherapy and Immune Responses1.6%
  • Other83.3%

Coauthors

All papers

Open in search
  1. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bo Gao, Brett Hughes, Girish Mallesara, Danny Rischin, Anne L. Taylor, Martin Burian, Thorsten Fuereder, Richard Greil, Carlos H. Barrios, Dalvaro Oliveira de Castro Junior, Gilberto de Castro, Fábio Franke, Gustavo Girotto, Iane Pinto Figueiredo Lima, Ulisses Ribaldo Nicolau, Gustavo Dix Junqueira Pinto, Lucas Vieira dos Santos, Ana-Paula Victorino, Neil Chua, Félix Couture, Richard Gregg, Aaron R. Hansen, John Hilton, Joy McCarthy, Denis Soulières, Rodrigo Ascuí, Pablo Gonzalez, Luis J. Villanueva-Rivera, Marco Torregroza, Ángela R. Zambrano, Petra Holečková, Zdeněk Král, Bohuslav Melichar, Prausova Jana, Milan Vošmik, Maria Andersen, Niels Gyldenkerne, Hannes Jürgens, Kadri Putnik, Petri Reinikainen, Viktor Gruenwald, Simon Laban, Gerasimos Aravantinos, Ioannis Boukovinas, Vassilis Georgoulias, Amanda Psyrri, D.L.W. Kwong, Yousuf Al-Farhat, Tibor Csőszi, József Erfán, Geza Horvai, László Landherr, Éva Remenár, Ágnes Ruzsa, Judit Szota, Salem Billan, Iris Gluck, Orit Gutfeld, Aron Popovtzer, Marco Benasso, Simona Bui, Vittorio Ferrari, Lisa Licitra, Franco Nolè, Takashi Fujii, Yasushi Fujimoto, Nobuhiro Hanai, Hiroki Hara, Koji Matsumoto, Kenji Mitsugi and 119 more - The Lancet 2019 cited by 3,211

  2. Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study

    Authors: , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2020 cited by 2,492

  3. Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study

    Authors: , , , , , , , , , , , , , , , , - Annals of Oncology 2022 cited by 445

  4. 2D Logistic-Sine-coupling map for image encryption

    Authors: , , , - Signal Processing, Signal Process. 2018 cited by 592

  5. Pembrolizumab in Patients With Microsatellite Instability–High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study

    Authors: , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 cited by 498

  6. Image Enhancement Guided Object Detection in Visually Degraded Scenes

    Authors: , , , , - IEEE Transactions on Neural Networks and Learning Systems, IEEE Trans. Neural Networks Learn. Syst. 2023 cited by 112

  7. Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey J. Legos, Fan Jin, Bijoyesh Mookerjee, Keith T. Flaherty - The Lancet 2015 cited by 1,386

  8. Tumor mutational burden predicts the efficacy of pembrolizumab monotherapy: a pan-tumor retrospective analysis of participants with advanced solid tumors

    Authors: , , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2022 cited by 161

  9. An Adversarial Time-Frequency Reconstruction Network for Unsupervised Anomaly Detection

    Authors: , , , , , - Neural Networks 2023 cited by 36

  10. Psl trails guide exploration and microcolony formation in Pseudomonas aeruginosa biofilms

    Authors: , , , , , , , , - Nature 2013 cited by 399

  11. Heterogeneity in surface sensing suggests a division of labor in Pseudomonas aeruginosa populations

    Authors: , , , , , , , , , , , , - eLife 2019 cited by 183

  12. Flagella and Pili-Mediated Near-Surface Single-Cell Motility Mechanisms in P. aeruginosa

    Authors: , , , , , , , , , - Biophysical Journal 2011 cited by 250

  13. Spatial profiling of microbial communities by sequential FISH with error-robust encoding

    Authors: , , , , , , - Nature Communications 2023 cited by 72

  14. Programming the lifestyles of engineered bacteria for cancer therapy

    Authors: , , , , , , , - National Science Review 2023 cited by 50

  15. How multisite phosphorylation impacts the conformations of intrinsically disordered proteins

    Authors: , - PLoS Computational Biology, PLoS Comput. Biol. 2021 cited by 81

  16. Prevalence of High Tumor Mutational Burden and Association With Survival in Patients With Less Common Solid Tumors

    Authors: , , , , , , , , , , , , - JAMA Network Open 2020 cited by 160

  17. Image Encryption Using Josephus Problem and Filtering Diffusion

    Authors: , , , - IEEE Access 2019 cited by 158

  18. Osmosensing by the bacterial PhoQ/PhoP two-component system

    Authors: , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2017 cited by 149

  19. Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE‐158 study

    Authors: , , , , , , , , , , , , , , , , - Cancer 2023 cited by 56

  20. Behaviour of cytoplasmic organelles and cytoskeleton during oocyte maturation

    Authors: , , , , - Reproductive BioMedicine Online 2013 cited by 157

  21. LBA41 LEAP-005: Phase II study of lenvatinib (len) plus pembrolizumab (pembro) in patients (pts) with previously treated advanced solid tumours

    Authors: , , , , , , , , , , , , , , , , - Annals of Oncology 2020 cited by 73

  22. Parental plasma concentrations of perfluoroalkyl substances and In Vitro fertilization outcomes

    Authors: , , , , , , , - Environmental Pollution 2020 cited by 58

  23. Multi-Modal Fusion Based on Depth Adaptive Mechanism for 3D Object Detection

    Authors: , , , , , - IEEE Transactions on Multimedia, IEEE Trans. Multim. 2023 cited by 20

  24. StyleBERT: Text-audio sentiment analysis with Bi-directional Style Enhancement

    Authors: , , , , - Information Systems, Inf. Syst. 2022 cited by 18